Human Mass Balance Study of [14C] Ontunisertib in Healthy Volunteers

Summary

This is an open, two-part study in healthy male volunteers, aged 30-65 years. This trial aims to understand how the human body absorbs, distributes, metabolizes and eliminates ontunisertib after a single oral dose of radiolabelled test medicine (\[14C\]ontunisertib) and determine the routes and rates of elimination of the test medicine.

Timeline

Start

2026-07-20

Primary completion

2026-12-31

Completion

2026-12-31

Drugs

Indications